Texas

Showing 11-16 of 16 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Localized immune modulation to enable long-term beta cell survival	William Marsh Rice University	Omid Veiseh	Cures	01-September-2022 to 31-August-2025	$600.000,00
Developing fusion therapeutics to selectively target beta cell surface receptors for treating T1D	UT Southwestern	Wen-hong Li	Cures	01-July-2022 to 30-June-2025	$900.000,00
Harnessing zinc-tropic agents for targeted delivery of therapeutics to islet beta cells for preventing or treating T1D	UT Southwestern	Wen-hong Li	Cures	01-August-2022 to 31-October-2025	$900.000,00
Investigation of novel local immunomodulating strategies to enhance islet transplantation for T1D	The Methodist Hospital Research Institute	Alessandro Grattoni	Cures	01-July-2022 to 30-June-2026	$962.995,99
Prevascularized encapsulation platform with local immunosuppression for Islet transplantation	The Methodist Hospital Research Institute	Alessandro Grattoni	Cures	01-August-2021 to 31-January-2026	$660.000,00
Can Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Mitigate Diabetic Ketoacidosis Risk?	University of Texas Health Science Center at San Antonio	Muhammad Abdul-Ghani	Improving Lives	01-June-2019 to 30-September-2025	$1.573.835,31